標(biāo)題: Titlebook: Cell Biology and Translational Medicine, Volume 11; Stem Cell Therapy - Kursad Turksen Book 2021 The Editor(s) (if applicable) and The Aut [打印本頁] 作者: CRUST 時(shí)間: 2025-3-21 19:50
書目名稱Cell Biology and Translational Medicine, Volume 11影響因子(影響力)
書目名稱Cell Biology and Translational Medicine, Volume 11影響因子(影響力)學(xué)科排名
書目名稱Cell Biology and Translational Medicine, Volume 11網(wǎng)絡(luò)公開度
書目名稱Cell Biology and Translational Medicine, Volume 11網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cell Biology and Translational Medicine, Volume 11被引頻次
書目名稱Cell Biology and Translational Medicine, Volume 11被引頻次學(xué)科排名
書目名稱Cell Biology and Translational Medicine, Volume 11年度引用
書目名稱Cell Biology and Translational Medicine, Volume 11年度引用學(xué)科排名
書目名稱Cell Biology and Translational Medicine, Volume 11讀者反饋
書目名稱Cell Biology and Translational Medicine, Volume 11讀者反饋學(xué)科排名
作者: adhesive 時(shí)間: 2025-3-21 23:12 作者: 蓋他為秘密 時(shí)間: 2025-3-22 02:03
Ordered Algebraic Structures in Analysisntial for cardiac regenerative medicine-based therapies. Their therapeutic potential has been widely investigated in various in-vitro and in-vivo preclinical models. Besides, they have been tested in clinical trials of MI and HF with various outcomes. Differentiation to lineages of cardiac cells, ne作者: bacteria 時(shí)間: 2025-3-22 05:01 作者: 富足女人 時(shí)間: 2025-3-22 09:13
Richard N. Ball,Anthony W. Hagerenesis has drastically expanded over the last decade with the definition of additional non-canonical roles in various tissues. Recently, tissue-resident immune cells have become an important research topic for understanding their roles in the prevention, pathogenesis, and recovery from the diseases.作者: Dungeon 時(shí)間: 2025-3-22 13:34
Partially Ordered *-Division Ringsuate level of control of the disease and management of diabetic patients remain a huge challenge. Because of the limitations of current therapies and the tremendous potential of non-conventional treatments such as stem cell therapy, herein, we review the applications of mesenchymal stem cells (MSCs)作者: Dungeon 時(shí)間: 2025-3-22 19:38 作者: 芭蕾舞女演員 時(shí)間: 2025-3-22 22:10 作者: Mercantile 時(shí)間: 2025-3-23 05:16 作者: malapropism 時(shí)間: 2025-3-23 08:30 作者: Little 時(shí)間: 2025-3-23 10:13 作者: Harbor 時(shí)間: 2025-3-23 16:46 作者: Diatribe 時(shí)間: 2025-3-23 18:42 作者: 斜谷 時(shí)間: 2025-3-24 00:01
Advances in Experimental Medicine and Biologyhttp://image.papertrans.cn/c/image/222739.jpg作者: 似少年 時(shí)間: 2025-3-24 03:09
Induced Pluripotent Stem Cell Derived Human Lung Organoids to Map and Treat the SARS-CoV2 Infectionver the next few months until the pandemic comes to an end, and a second wave has also been reported in few countries. Most interestingly, the death rate among certain populations from the same COVID-19 infection is highly variable. For instance, the European populations show a very high death rate,作者: 漸變 時(shí)間: 2025-3-24 10:29 作者: ANTH 時(shí)間: 2025-3-24 11:39
Functions of Mesenchymal Stem Cells in Cardiac Repair,ntial for cardiac regenerative medicine-based therapies. Their therapeutic potential has been widely investigated in various in-vitro and in-vivo preclinical models. Besides, they have been tested in clinical trials of MI and HF with various outcomes. Differentiation to lineages of cardiac cells, ne作者: malapropism 時(shí)間: 2025-3-24 17:02
Cardiac Progenitor Cells,h very limited regenraive capacity. Stem cell therapy has shown great potential for treatment of cardiovascular diseases in the experimental setting, but success in human trials has been limited. Applications of stem cell therapy for cardiovascular regeneration necessitate understamding of the compl作者: BLAND 時(shí)間: 2025-3-24 20:54
Cardiac Immunology: A New Era for Immune Cells in the Heart,enesis has drastically expanded over the last decade with the definition of additional non-canonical roles in various tissues. Recently, tissue-resident immune cells have become an important research topic for understanding their roles in the prevention, pathogenesis, and recovery from the diseases.作者: happiness 時(shí)間: 2025-3-25 02:04
Conventional and Alternative Mesenchymal Stem Cell Therapies for the Treatment of Diabetes,uate level of control of the disease and management of diabetic patients remain a huge challenge. Because of the limitations of current therapies and the tremendous potential of non-conventional treatments such as stem cell therapy, herein, we review the applications of mesenchymal stem cells (MSCs)作者: indifferent 時(shí)間: 2025-3-25 05:51
Mesenchymal Stem Cells: The Past Present and Future,m various tissue types (e.g. bone marrow, fat, cord blood, etc.), are capable of self-renewal, and could be induced to differentiate into several cell lineages for countless biomedical applications. In addition, when transplanted, MSCs are not detected by immune surveillance, thus do not lead to gra作者: HATCH 時(shí)間: 2025-3-25 08:01
Extracellular Vesicle Therapeutics in Regenerative Medicine, EVs play an important role in intercellular communication and influence both physiological and pathological conditions. They are increasingly explored as potential therapeutic agents since they can cross biological barriers, their cargo is protected from degradation and they are involved in the tra作者: Increment 時(shí)間: 2025-3-25 14:56
Exosomes as Part of the Human Adipose-Derived Stem Cells Secretome- Opening New Perspectives for Cew immunogenicity, high proliferative rate and potential to differentiate on multiple lineages. Their secretome is rich in chemokines, cytokines and protein growth factors that are actively involved in regeneration processes. In addition, part of this secretome are also the exosomes (hASC-exos), whic作者: CODA 時(shí)間: 2025-3-25 15:53 作者: 譏笑 時(shí)間: 2025-3-25 22:56
Embryonic Stem Cells in Clinical Trials: Current Overview of Developments and Challenges, research and discussion. Despite considerable studies to Date, hESC-based therapy is not available for conventional clinical applications, and more studies and data are needed to overcome current clinical and ethical limitations. When all the limitations of Embryonic stem cells (ESC) are wholly res作者: Range-Of-Motion 時(shí)間: 2025-3-26 00:55
Cardiac Immunology: A New Era for Immune Cells in the Heart,s myocardial infarction, autoimmune cardiac diseases, or infectious cardiac diseases, such as myocarditis, endocarditis, and acute rheumatic carditis. Following cardiac injury, innate and adaptive immunity have critical roles in pro- and anti-inflammatory processes. Heart resident immune cells not o作者: nugatory 時(shí)間: 2025-3-26 06:52
Exosomes as Part of the Human Adipose-Derived Stem Cells Secretome- Opening New Perspectives for Ce alternative to standard therapies used in regenerative medicine, as a cell-free new approach with multiple possibilities to be modulated according to the patient needs. This review offers an updated overview on the functions and applications of hASC-exos in all areas of tissue regeneration, aiming 作者: Infelicity 時(shí)間: 2025-3-26 10:37 作者: 發(fā)酵劑 時(shí)間: 2025-3-26 13:28
The Declaration of Independence,e have reviewed virus-transmitted various respiratory tract infections and postulated a better understanding of SARS-CoV2 using lung stem cell organoids .. Hence, here we propose the strategies of understanding first the infectivity/severity ratio of COVID-19 infections using various ethnicity origi作者: 蛙鳴聲 時(shí)間: 2025-3-26 18:58
https://doi.org/10.1007/978-94-009-2434-5 research and discussion. Despite considerable studies to Date, hESC-based therapy is not available for conventional clinical applications, and more studies and data are needed to overcome current clinical and ethical limitations. When all the limitations of Embryonic stem cells (ESC) are wholly res作者: GONG 時(shí)間: 2025-3-26 23:42
Richard N. Ball,Anthony W. Hagers myocardial infarction, autoimmune cardiac diseases, or infectious cardiac diseases, such as myocarditis, endocarditis, and acute rheumatic carditis. Following cardiac injury, innate and adaptive immunity have critical roles in pro- and anti-inflammatory processes. Heart resident immune cells not o作者: 啜泣 時(shí)間: 2025-3-27 01:09
Methods of Structural Optimization, alternative to standard therapies used in regenerative medicine, as a cell-free new approach with multiple possibilities to be modulated according to the patient needs. This review offers an updated overview on the functions and applications of hASC-exos in all areas of tissue regeneration, aiming 作者: 蚊子 時(shí)間: 2025-3-27 08:58 作者: notion 時(shí)間: 2025-3-27 12:47 作者: minion 時(shí)間: 2025-3-27 16:38 作者: inscribe 時(shí)間: 2025-3-27 20:58
Conventional and Alternative Mesenchymal Stem Cell Therapies for the Treatment of Diabetes,h in animal models and human clinical trials for the treatment of diabetes. This review will summarize the latest experimental and clinical studies that have provided evidence of the beneficial role of MSCs in diabetes treatment.作者: 做事過頭 時(shí)間: 2025-3-27 22:25 作者: 難理解 時(shí)間: 2025-3-28 05:26 作者: 整體 時(shí)間: 2025-3-28 08:19
Ordered Algebraic Structures in Analysis suggests that secretomes of MSCs and/or their extracellular vesicles play significant roles in a paracrine manner while mediating these functions. This chapter aims to summarize and highlight cardiac repair functions of MSCs during cardiac repair.作者: 欺騙手段 時(shí)間: 2025-3-28 11:32 作者: 異端 時(shí)間: 2025-3-28 17:55
Organization and Decision Theorysimilar to any other therapeutic tool, MSCs still have their own limitations and grey areas that entail more research for better understanding and optimization. Herein, we present a brief overview of various pre-clinical/clinical applications of MSCs in regenerative medicine and discuss limitations and future challenges.作者: 擴(kuò)音器 時(shí)間: 2025-3-28 21:26 作者: minaret 時(shí)間: 2025-3-29 01:33
Cardiac Progenitor Cells,of cardiac tissue, and the major findings on the development of cardiac stem cells, their characterization, and differentiation, and their regenerative potential. It concludes with clinical applications in treating cardiac disease using different approaches, and concludes with areas for future research.作者: EVEN 時(shí)間: 2025-3-29 07:04
Mesenchymal Stem Cells: The Past Present and Future,similar to any other therapeutic tool, MSCs still have their own limitations and grey areas that entail more research for better understanding and optimization. Herein, we present a brief overview of various pre-clinical/clinical applications of MSCs in regenerative medicine and discuss limitations and future challenges.作者: 止痛藥 時(shí)間: 2025-3-29 08:38
